Estrologo, Danilo F.

HRN: 21-45-45  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2023
CEFTRIAXONE 1G (VIAL)
01/01/2023
01/07/2023
IV
2g
OD
CAP MR
Waiting Final Action 
01/01/2023
AZITHROMYCIN 500MG TABLET (TAB)
01/01/2023
01/05/2023
PO
500mg
OD
CAP MR
Waiting Final Action 
01/02/2023
CEFTAZIDIME 1GM (VIAL)
01/02/2023
01/22/2023
IVT
1g
Q8
Community Acquired Pneumonia
Waiting Final Action 
01/08/2023
CEFTAZIDIME 1GM (VIAL)
01/08/2023
01/14/2023
IV
2gm
Q8
Cap HR
Waiting Final Action 
01/08/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
01/08/2023
01/14/2023
IV
750mg
Q24
Cap Hr
Waiting Final Action 
01/08/2023
CEFTAZIDIME 1GM (VIAL)
01/08/2023
01/14/2023
IV
2gm
Q8
Acute Respiratory Failure Secondary To Cap HR - (7th Day- Increase Dose From 1gm To 2gm Q8)
Waiting Final Action 
01/11/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/11/2023
02/03/2023
IV
4.5g
Q8h
CAP HR
Waiting Final Action 
01/12/2023
CLARITHROMYCIN 500MG (CAP)
01/12/2023
01/21/2023
ORAL
500mg
Bid
Cap HR
Waiting Final Action 
01/18/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/18/2023
01/21/2023
IV
4.5 Grams
Q 8 Hours
Cap
Waiting Final Action 
02/03/2023
CEFUROXIME 1.5GM (VIAL)
02/03/2023
02/04/2023
IVT
750 Mg
Q8h
S/p Tracheostomy, (post Op Orders By Anaesth. COD)
Waiting Final Action 
02/04/2023
CEFTRIAXONE 1G (VIAL)
02/04/2023
02/10/2023
IVT
2 G
Once A Day
UTI; Post Tracheostomy
Waiting Final Action 
02/11/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
02/11/2023
02/18/2023
IV
750mg
OD
Ongoing UTI
Waiting Final Action 
02/27/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/27/2023
03/06/2023
IV
2.25gms
Q8
CAP HR
Waiting Final Action 
03/06/2023
CEFIXIME 200MG (CAP)
03/06/2023
03/12/2023
ORAL
200mg
Q12
CAP HR (resolving)
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: